A myeloid neoplasm NGS performed on DNA from peripheral blood cells revealed an MDS associated U2AF1 mutation (NM_006758.2: c.470A>G) with an allele burden of 24%. The gene discussed is U2AF1; the disease is myelodysplastic syndrome.